Smooth muscle proliferation has been recognized as central to the pathology of both major forms of vascular disease: atherosclerosis and hypertension. Recent advances in our knowledge of mechanisms of control of proliferation suggest that events occurring in adult animals may recapitulate portions of the developmental biology of the smooth muscle cell. This review attempts to consider the current state of knowledge of the mechanisms controlling smooth muscle proliferation in these two diseases, to put that knowledge into the context of what is known about smooth muscle biology, and to offer two hypotheses on the possible roles of smooth muscle developmental biology in manifestations of atherosclerosis and hypertension in adult humans. (Circ Res 58: 427-444, 1986) 
SUMMARY.
Smooth muscle proliferation has been recognized as central to the pathology of both major forms of vascular disease: atherosclerosis and hypertension. Recent advances in our knowledge of mechanisms of control of proliferation suggest that events occurring in adult animals may recapitulate portions of the developmental biology of the smooth muscle cell. This review attempts to consider the current state of knowledge of the mechanisms controlling smooth muscle proliferation in these two diseases, to put that knowledge into the context of what is known about smooth muscle biology, and to offer two hypotheses on the possible roles of smooth muscle developmental biology in manifestations of atherosclerosis and hypertension in adult humans. (Circ Res 58: 427-444, 1986) THE purpose of this article is to review current knowledge of the developmental biology of vascular smooth muscle cells. We will suggest that smooth muscle proliferation in both atherosclerosis and hypertension results from processes similar to events occurring during differentiation of the vascular smooth muscle cell.
Development of the Artery
Blood vessels arise from mesenchyme as a budding network of small endothelial-lined channels (Sethi and Brookes, 1971) . These channels become surrounded by locally derived, irregularly shaped mesenchymal cells lacking smooth muscle cell-specific features (Manasek, 1971; De Simone-Santoro and Renda, 1971; Blatt, 1973; Gonzalez-Crussi, 1971) . With time, cell layers delimited by elastic lamellae become more identifiable in large arteries, and the cells take on a more characteristic ultrastructural appearance (Karrer, 1961) . At parturition, most arteries appear to have developed their adult number of layers of smooth muscle (Wolinsky and Glagov, 1967) . After this stage, the number of layers in the wall does not increase, and the medial thickening is due to the production of connective tissue (Gerrity and Cliff, 1975) .
The signals controlling this differentiation of smooth muscle cells are not known. The fact that vessels begin as endothelial channels suggests that endothelium signals differentiation of smooth muscle cells from the surrounding embryonic melieu. Very little is known about this process. In one set of experiments, an attempt was made to explore the ability of adult bovine endothelial cells to induce changes in the developing chick embryo. Despite the obvious species barrier, these endothelial cells elicited a marked angiogenic response. Whether this suggests the presence of a differentiational hormone or a response to foreign cells is unclear. However, bovine fibroblasts and smooth muscle cells were not similarly angiogenic (Harris-Hooker et al., 1983) . At a more mechanical level, the increase in blood pressure observed throughout development has been considered by many workers to be responsible for the growth and differentiation of the media of large vessels (Thoma, 1893 , as quoted in Berry, 1974 .
Increases in the extent of innervation seen during pre-and postnatal development could correlate with changes in expression of contractile protein also seen after birth (Mort, 1961; Burnstock et al., 1980; Kocher et al., 1985) . Trophic and tropic influences of developing and regenerating sympathetic nerves have been shown in developing and mature smooth muscle cells in culture (Chamley-Campbell and Campbell, 1983) , but similar studies have not yet been performed on blood vessels in vivo.
Biochemical Markers of Development and Differentiation
The expression of cytoskeletal and contractile proteins in skeletal muscle has provided an excellent model of biochemical parameters that may be useful in describing development and differentiation of smooth muscle cells. The proteins studied thus far in both types include actin and myosin which are essential for the most characteristic function of smooth muscle cells-the ability to contract. Moreover, they include specific isotypes characteristic of the differentiatdonal states.
Three different isoforms of actin have been distinguished in arteries-a-, fi-, and 7-actin . In the normal adult aorta, smooth muscle cells of the media show a predominance of a-actin, some /3-actin, and very little 7-actin, whereas, in the fetus and newborn animal, the j3-isoform predominates . Mammalian nonmuscle cells, including fibroblasts, contain only the /S-and 7-isoforms . No variation in actin isoform to date has been reported throughout the adult vascular tree except after arterial injury Kocher et al., 1984) .
Myosin from smooth and striated muscle differs not only in amino acid composition (Hamoir, 1973) , the type of light chains, and chemical properties of the myosin molecules (Hartshorne and Gorecka, 1980) , but, also, in the way the molecules assemble into filaments (Small and Sobieszek, 1980) . Cardiac muscle myosin can be found in three isoenzymatic forms which have been designated VI, V2, and V3 (Hoh et al., 1977) . To date, a similar resolution of myosin variants has not been shown in smooth muscle, although several studies suggest they do exist. Antibodies directed against the heavy meromyosin end of chicken gizzard smooth muscle myosin intensely stain contractile state smooth muscle cells in culture and in vivo, but not synthetic state smooth muscle cells or fibroblasts (Groschel-Stewart et al., 1975) . Antibodies to the same portion of the myosin molecule from human uterus stain both contractile and synthetic smooth muscle cells, as well as fibroblasts (Burkl et al., 1979) . White et al. (1983) has also demonstrated a similar heterogeneity of myosin antigenic expression, but their human uterine myosin antibody does not stain fibroblasts or smooth muscle cells in small arteries or veins. Murphy et al. (1977 Murphy et al. ( ,1983 found biochemically that, while the concentration of myosin does not vary appreciably throughout a range of visceral and vascular smooth muscles, the concentrations of actin and tropomyosin are almost twice as high in arterial tissue as in veins or visceral muscles, giving a ratio of actin to myosin of about 1.8 for veins and visceral muscle and about 3.0 for arterial muscle.
In addition to contractile proteins, the cytoplasm contains structural proteins which change with differentiation. Mature smooth muscle cells contain two classes of intermediate filament proteins: vi-Circulation Research/Vol. 58, No. 4, April 1986 menn'n, which is found in most cell types, and desmin, which is found only in muscle cells (Lazarides, 1982) . Mature visceral smooth muscle contains predominantly desmin Richardson et al., 1981) , but vascular smooth muscle expresses various ratios of desmin and vimentin (Bermer et al., 1981; Frank and Warren, 1981; Gabbiani et al., 1981) . Rat aortic medial smooth muscle cells contain 51% vimentin alone-positive cells, 48% with both vimentin and desmin, and 1% desmin alone . More desmin-positive cells are present in the aorta toward the iliac arteries than at the arch (Osborn et al., 1981; Schmid et al., 1982) . Vimentin is found in 87% of the medial cells in the fetal aorta, 13% contain both vimentin and desmin, and none contain desmin alone. With development, there is a gradual decrease in cells containing vimentin alone and an increase in cells in which both vimentin and desmin coexist until adult values are reached 12 weeks after birth (Kocher et al., 1985) .
In addition to the major intermediate filament proteins, a number of intermediate filament-associated proteins have also been identified (Price and Lazarides, 1983) . Two of these proteins are synemin (Granger and Lazarides, 1980) and paranemin (Breckler and Lazarides, 1982) . Developing chicken vascular and visceral smooth muscle simultaneously express desmin, vimentin, paranemin, and synemin. However, during development, the expression of paranemin and vimentin is altered in some tissues such that in the adult, visceral muscle expresses desmin and synemin alone, elastic arteries express paranemin,-desmin, vimentin and synemin, whereas muscular arteries do not contain paranemin but express desmin, vimentin, and synemin (Price and Lazarides, 1983) . Since the functions of paranemin and synemin are unknown, the significance of these changes has yet to be determined.
As summarized in Table 1 , these changes represent a phenomenological collection. It seems likely, however, that molecular biology and the increasing understanding of developmental biology will lead us to mechanisms for the coordinate control of these proteins having related functions.
Mechanism Controlling Phenotypic Expression
Since very little is known about smooth muscle differentiation, it may be worth considering briefly the control of expression of cytoskeletal proteins in developing skeletal muscle. Rhabdomyoblasts, the precursor cells to skeletal muscle, appear very much like fibroblasts. This is true by morphological, immunocytochemical, protein biochemical, and polynucleotide hybridization criteria (Nguyen et al., 1983; Schwartz, 1984) . These undifferentiated cells require growth factors for proliferation (Iim and Hauschka, 1984) . When growth factors are removed from the medium, the cells rapidly change phenotype. Within 24 hours, genes for characteristic muscle proteins of skeletal muscle are turned on and 
Decrease in a-actin content may correlate with loss of contractility, a exists as a smooth muscle-specific isoform and no aisoform is seen in nonmuscle cells. /3 is a non-muscle actin.
•y exists as both smooth muscle-specific and nonmuscle isoforms.
Higher myosin concentration in visceral and venous than arterial muscle
These proteins polymerize to form the 100 A 'intermediate* filaments characteristic of most mesenchymal cells. Vimentin is found in all cells. Desrrun is restricted to muscle cells (striated and smooth).
* Non-muscle-specific analogues of muscle-specific proteins proteins are produced. Simultaneously, the cells become refractory to any further stimulation of DNA synthesis by mitogens. Linkage between differentiation and loss of replicative capacity seems to be under the control of a single gene. This is supported by an observation of Nadal-Ginard and his collaborators. They reported development of a temperature-sensitive mutant in which the linkage between differentiation and proliferation lost at high temperature. That is, expression of the differentiated phenotype is reversible at high temperature by the addition or subtraction of mitogen, and mitogenderived cells will also replicate when exposed to more growth factor. At low temperature, loss of replicarive ability and expression of a differentiated phenotype appear together (Nguyen et al., 1983) . This skeletal muscle cell mutant may serve as a model for smooth muscle differentiation, that is, for examining the reversibility of the differentiated smooth muscle phenotype. Much of the evidence for reversibility of the differentiated smooth muscle phenotype comes from cell culture studies. When the media of adult arteries is enzyme-dispersed into single smooth muscle cells and seeded into primary culture, the cells are morphologically and functionally similar to those of the intact vessel, that is, they either spontaneously contract or can be induced to contract by electrical, mechanical, or chemical stimuli, and they synthesize only small amounts of extracellular matrix material. However, if these cells are seeded below a critical cell density, after about 1 week, the cells undergo a spontaneous change in phenotype (Chamley et al., 1977) . Functionally, they lose the capacity to contact and gain the capacity to divide, and do so logarithmically in response to serum mitogens . As well, they synthesize four to five times the amount of extracellular matrix molecules as the contractile state cells (Campbell and Campbell, 1986b) . Morphologically, the cells lose their thick, myosincontaining filaments and greatly increase the amount of organelles involved with synthesis, such as rough endoplasmic reticulum and free ribosomes Thyberg et al., 1983 Thyberg et al., , 1985 , to resemble immature smooth muscle cells. These two distinct phenotypes have been termed 'contractile* and 'synthetic* (Fig. 1) . These are only two points on a continuous spectrum of smooth muscle phenotypic expression, and cells having features of both contractile and synthetic cells exist.
This association of morphological changes and cell replication suggests something similar to, although reversed from, the correlation of differentia-FIGURE 1. a: 7-week-old rabbit aorta 4 days in primary culture.
Smooth muscle cells have an appearance similar to those of the intact media, that is, they are toward the contractile phenotype, with much of their cytoplasm filled with myofilaments. Bar = 2 fim. b: 7-weekold rabbit aorta 11 days in culture, first subculture. Smooth muscle cells are in the synthetic phenotype. Although a filament bundle extends along the right hand side of the cell (note plasmalcmmal vesicles of cell membrane), most of the cytoplasm is filled with organdies associated with synthesis. Bar = 2 pm. c: two smooth muscle cells from the neointima formed in the carotid artery of a rabbit 2 weeks after endothelial denudation. Both cells are in the synthetic phenotype containing a few filaments but a large number of synthetic organelles. Bar = 2 iim.
Circulation Research/Vol. 58, No. 4, April 1986 tion with loss of replication in skeletal muscle myoblasts. As with the skeletal muscle cells, cells can express the "contractile' phenotype when they return to a quiescent state. Cells in primary culture that have been plated at high but subconfluent densities proliferate to a confluent monolayer. These cells spontaneously revert to the contractile state 1 or 2 days after achieving confluence ('reversible synthetic' cells) (Chamley et al., 1974; . In contrast, cells that have been seeded so sparsely that the synthetic state cells require more than 2-3 weeks to achieve confluence do not return to the contractile state, and appear "irreversibly synthetic' Subcultured cells beyond passage 1 or 2 are in the irreversible synthetic state. suggested that this change from a contractile phenotype, that is, from a cell with an extensive array of contractile filaments to a synthetic phenotype characterized by extensive rough endoplasmic reticulum, is a prerequisite for cellular proliferation. This has been confirmed by Thyberg et al. (1983 Thyberg et al. ( , 1985 . However, Alexander and his colleagues have reported smooth muscle cells that retain the ability to contract after serial passage (Larson et al., 1984a (Larson et al., , 1984b . This may be related to the observation of Chamley et al. (1974) that about 5% of smooth muscle cells do not change to the synthetic state, but remain contractile, or else the correlation of morphology with the ability to divide may not be absolute. This latter suggestion, i.e., the possibility that modulation between a 'contractile' and a 'synthetic' phenotype, is supported by studies of a high dedifferentiated rat smooth muscle cell line. BC3HI cells express the actin isoform characteristic of smooth muscle cells at low levels. When these cells are induced to differentiate by serum deprivation or cell-cell contact, smooth muscle-specific actin synthesis is induced, and nonmuscle actins are repressed. This suggests a reversible link between the two cell phenotypes at the level of gene expression, although the relationship to the full reestablishment of a contractile state in any cultured smooth muscle cell remains to be established (Strauch and Rubenstein, 1984) .
Similar changes from a 'contractile' to a 'synthetic' mode can be correlated with changes at a biochemical level. In primary cell culture, the actin isofonns and intermediate filaments of smooth muscle cells change with time. Desmin is lost and aactin content is low or absent . The cells also lose their ability to stain with fluoresceinated antibodies to the heavy meromyosin end of the smooth muscle myosin molecule concomitant with a loss in the ability to demonstrate ultrastrucrurally thick myosin-containing filaments . Interestingly, in a clonal cell line derived from mouse brain, the expression of aisoactin can be increased 3-fold by making the cells quiescent in serum-free medium when there is extensive cell-to-cell contact (Strauch and Rubenstein, 1984) . This actin is smooth muscle specific, suggest-ing that an established smooth muscle cell line shows a linkage of expression of a differentiated phenotype and loss of replication much as seen when rhabdomyoblasts are deprived of their growth medium.
Phenotypic Expression in Artery Regeneration
Injury to the endothelium has been caused experimentally by a variety of traumas (Baumgartner and Studer, 1966; Veress et al., 1969; Stemerman and Ross, 1972; Bjorkerud and Bondjers, 1973; Knieriem et al., 1973; Fishman et al., 1975; Schwartz et al., 1975; van Pelt-Verkuil et al., 1983) . Small wounds heal without stimulation of smooth muscle replication (Reidy and Schwartz, 1984) . If the damage is of sufficient size Bondjers, 1971, 1973) , smooth muscle cells from the media migrate to the intima where they subsequently proliferate, forming a neointima of longitudinally orientated smooth muscle cells. These cells are ultrastructurally equivalent to the synthetic state cells in culture, with large amounts of rough endoplasmic reticulum, free ribosomes, and mitochondria, and a reduced number of myofilaments (Fig. 1C ), and the changes persist up to 3 weeks after endothelial injury (Knieriem et al., 1973; Fishman et al., 1975; Schwartz et al., 1975; Spaet et al., 1975; Clowes and Karnovsky, 1977; Guyton and Karnovsky, 1979; Haudenschild and Schwartz, 1979; Taura et al., 1979; Campbell et al., 1983; Clowes et al., 1983; Larrue et al., 1984) . Upon reestablishment of the overlying endothelial layer, the smooth muscle cells of the neointima return to the contractile state, regaining an apparently normal complement of myofilaments with a concomitant decrease in the amount of synthetic organelles (Clowes et al., 1983; Larrue et al., 1984) . This sequence is also seen in biochemical and immunocytochemical studies of the expression of contractile and cytoskeletal proteins. Fifteen days after injury, cells that have migrated into the intima contain decreased amounts of actin and desmin and increased amounts of vimentin Kocher et al, 1984) . Moreover, /S-actin is the predominant actin isotype in these cells, and significant amounts of 7-actin appear, whereas a-actin decreases (see Fig. 2 ). Seventy-five days after injury, when the endothelium has completely regenerated, the cytoskeletal elements of the neointimal smooth muscle cells are similar to those of the media. Studies using antibodies to the heavy meromyosin end of smooth muscle myosin (Groschel-Stewart et al., 1976 ) demonstrate a loss of myosin at 14 days after endothelial denudation, with a return to near normal levels by 8 weeks (Campbell and Campbell, 1986a) .
Smooth Muscle Replication in Arteriosclerosis
The major reason for considering the association of proliferation and differentiation is the central role that smooth muscle cell replication plays in atherosclerosis and hypertension. Smooth muscle cells may 431 f}' .
• i ,
FIGURE 1. Absence of smooth muscle actin in proliferating smooth muscle cells. This figure shows a rat carotid artery 2 weeks after balloon injury. The smooth muscle cells in the media stain intensely with an antibody to smooth muscle actin (Gown et al., 1985). The proliferating smooth muscle cells in the intima are negative with this antibody. At this point in time, the cells of the intima are actively proliferating (peroxidase labeled secondary antibody; primary antibody mouse monoclonal, 350X). Illustration provided by Dr. David Cordon.
be stimulated to undergo at least two distinct proliferative responses, true replication and endoreplication. These types of replication characterize the pathological responses seen in hypertension and atherosclerosis. However, as we will discuss, it is possible that the proliferative response itself is a central factor in the etiology of both diseases. Four questions need to be considered for each disease: (1) Is replication itself a cause or a result of the disease? (2) What causes the replication? (3) How does replication affect clinical outcome? (4) What controls the forms of replication seen in atherosclerosis and hypertension?
Atherosclerosis

Is Replication a Result or Cause of the Disease?
Although it is now generally acknowledged that replication of smooth muscle cells occurs during formation of atherosclerotic lesions, the role of that proliferative response in the overall history of the plaque is not at all obvious. A few investigators have suggested that replication occurring during development of arteries is the initial event in formation of atherosclerotic lesions, preceding lipid accumulation or endothelial injury. The best evidence in support of this hypothesis comes from studies of very early lesions in man and in animals. In an extensive postmortem study of coronary arteries in subjects whose age ranged from fetal to 40 years, Velican (1976, 1980) found that atherosclerotic plaques develop within preexisting intimal thickenings. The vast majority of cells in these diffuse intimal thickenings are smooth muscle (Greer and Haust, 1972; Orekhov et al., 1984) . Plaques themselves consist of a focal proliferation of smooth muscle cells and accumulation of foam cells and extracellular lipid within the thickenings. These muscle cells have a substantially different morphology from those of the media. For instance, the volume fraction of synthetic organelles in many smooth muscle cells in intimal thickenings near lesions from human carotid endarterectomy material is greatly increased compared with cells of the media (Mosse et al., 1985) . Consistent with this is the recent observations of Gabbiani et al. (1984) that, unlike the aortic media, which shows a predominance of actin in the a-isoform, human atheromatous plaques and surrounding diffuse intimal thickenings show a predominance of /S-actin with a 7-isoform. These features are reminiscent of cultured smooth muscle cells in the synthetic state or smooth muscle cells which have been stimulated to migrate or replicate in response to denudation.
Data similar to that of the Velicans exist in a swine model of atherosclerosis. Intimal cell masses in the normal swine, unlike the media, show a high constant rate of cell birth and death involving approximately 40% of the smooth muscle cell population over a 60-day period, with no increase in cell number under normal circumstances (Thomas and Kim, 1983) . The cause of the very high rate of turnover of smooth muscle cells is unknown. Thomas and his colleagues find that the proliferative response to hyperlipemia occurs focally in these preexisting intimal cell masses present in specific anatomical sites from birth (Thomas and Kim, 1983) . If the Velicans' model is correct, then the development of these masses may represent the initial event of atherogenesis in both species.
As we will discuss later, the idea that atherosclerosis may begin during development has important implications for current concepts of the etiology of lesions. If, for example, scattered cells located in the developing intima were to proliferate in a focal fashion to form Thomas's "intimal cell masses,' we might expect to find that adult lesions originating in preexisting clones of intimal cells would appear to be of monoclonal origin. This has been described by Benditt and others (Gown and Benditt, 1982) .
What Causes the Replication?
The major hypothesis explaining smooth muscle replication in the vessel wall is the response-toinjury hypothesis of Ross. In brief, he proposed that smooth muscle cells in the wall normally exist in a quiescent state. When the endothelium was injured, platelets released a factor or factors that stimulated smooth muscle cell movement into and replication within the arterial intima (Ross, 1981) This hypothesis was based on the observation that endothelial denudation of arteries by a balloon embolectomy catheter produces intimal proliferation. Immediately after balloon catheterization, the denuded surface shows a prominent platelet carpet. Anti-platelet serum inhibits the smooth muscle proliferative response (Friedman et al., 1977) . Ross also showed that cultured smooth muscle cells require a platelet-Circularion Research/Vol. 58, No. 4, April 1986 derived growth factor (PDGF) for proliferation (Ross and Glomset, 1976) . The apparent conclusion is that platelet release is necessary for the smooth muscle proliferative response to balloon denudation. As we will discuss later, it is not unreasonable to propose that this mechanism also occurs in hypertension, particularly in small arteries.
Ross's observation led to the ensuing purification of the PDGF, identification of its receptor (Ross and Glomset, 1976; Heldin et al., 1979) , and, more recently, identification of the oncogene c-sis as the gene for one of the two PDGF peptide chains (Doolittle et al., 1983; Waterfield et al., 1983) . PDGF binds to a specific receptor found on smooth muscle cells, but is absent on endothelial cells (Bowen-Pope and Ross, 1982) . Once bound, PDGF initiates a series of events leading to DNA synthesis. These events include initiation of a chain of protein phosphorylations and internalization of the receptor complex (Ross and Glomset, 1976) .
The second known requirement for cell cycle progression is availability of somatomedin C, also known as insulin-like growth factor (IGF-1) (Clemmons et al., 1983) . IGF-1 itself can be synthesized by smooth muscle cells, and antibodies to IGF-1 inhibit cell cycle progression. These data suggest that PDGF is capable of stimulating production of its own progression factor. As we will discuss later, this observation is of considerable importance to the interesting possibility that smooth muscle replication may be controlled by factors intrinsic to the vessel wall. It is important to point out that these phenomena may be quite general. PDGF and IGF-1 are able to stimulate replication in a wide variety of mesenchymal cells, and c-sis is homologous to the transforming sequences of the viral oncogene, v-sis, that transforms a similar range of cells. The specificity of the process here lies in the idea that PDGF is not normally available to the adult smooth muscle cell unless delivered to the wall by platelets or, as we will see, other leukocytes arriving at a site of injury.
Before leaving the topic of mitogens derived from blood-borne cells, it is important to point out that in vivo there are other substances mitogenic for smooth muscle cells, apart from PDGF. In addition, platelets also contain a protein resembling epidermal growth factor (EGF) (Oka and Orth, 1983; Assoian et al., 1984) and a factor able to assist growth of cells in suspension called /3 tumor growth factor (Tucker et al., 1984) . The relative contribution of each of these to stimulation of proliferation is largely unknown. Finally, in fat-fed models, the most obvious stimulus may be a growth factor derived from monocytemacrophages since these cells accumulate in the intima soon after commencement of a high-fat diet (Gerrity, 1981; Faggjotto et al., 1984) . These monocytes could be critical to smooth muscle proliferation. In vitro, monocytes or macrophages produce an as yet unidentified polypeptide mitogen (Leibovitch and Curwen et al., 1980) . Recent evidence has shown that at least some of this mitogen is similar or identical to PDGF, however, (Shimokado et al., 1985) . As a general model for atherosclerosis, however, the endothelial denudation model has a number of shortcomings, the most critical being that, in fat-fed animals, denudation does not appear until after initial events in the development of atherosclerotic lesions Walker et al., 1984) . Recent studies on fat-fed animals shows a rapid initial monocytosis of the vessel wall with invasion and formation of intimal foam cell masses. At this point, endothelial continuity is still present (Goode et al., 1977; Walker et al., 1984) . As the foam cell masses progress, discontinuities occur and platelet interaction begins (Faggiotto and . What causes this endothelial disruption is unknown, but it is interesting to note that activated leukocytes can cause discontinuity of endothelial cell monolayers, either by cell death (Boogaerts et al., 1982) or by nonlethal mechanisms (Harlan et al., 1981; Territo et al., 1984) . The relationship of this disruption to the initiation of smooth muscle replication is an important unknown. Although some studies show that smooth muscle proliferation occurs prior to denudation (Scott et al., 1979; Walker et al., 1984) , it remains possible that the advent of thrombosis is crucial to an accelerated period of lesion growth or even to the conversion from a nonclinically important fatty streak to a classical fibromuscular atherosclerotic plaque (McGill, 1984) .
If the balloon model is appropriate as a model for the initiating events, one might expect small denuding wounds to produce focal lesions. This does not appear to be the case. When selective lesions are made in widths ranging from 1 cell to 100 endothelial cells, no smooth muscle stimulation occurs (Reidy and Silver, 1985) . This result may be explained in a number of ways. One might imagine that rapid reendothelialization would prevent smooth muscle proliferation by reestablishing a nonthrombogenic surface. However, kinetic studies of thrombosis show that most of the interaction is over by 1 hour, while DNA synthesis does not occur until 1-2 days (Groves et al., 1979; Clowes and Schwartz, 1985) . Since the selectively denuded areas remain exposed for as long as 1 week, the platelet response seems likely to be similar in both selective denudation and balloon denudation. This suggests that effects of balloon denudation other than platelet release are involved in the maintenance of proliferation.
One possibility comes from evidence that the normal vessel wall contains inhibitors of smooth muscle proliferation. Clowes and Karnovsky (1977) discovered that exogenous heparin could inhibit proliferation in response to removal of the endothelium. This effect may have mimicked the actions of a growth inhibitor normally present in the intact, uninjured vessel wall. In 1936, Simms and Srillman first discovered that the aorta contains growth inhibitory substances. Florentin et al. (1973) showed that an aqueous extract of pig aorta injected intraperitoneally into 8-week-old living swine, in quantities as low as 500 /ig of protein, drastically reduced the rate of entry of arterial smooth muscle cells into mitosis, with no demonstrable affect on epidermal mitosis. Eisenstein et al. (1979) reported two classes of molecules derived from bovine aortic extracts that are able to inhibit cell growth. One class, comprised of structural polyanions, including heparans and proteoglycans, inhibited the growth of both smooth muscle and endothelial cells. Alcohol precipitates from aqueous extracts of the pig intima plus media were fractionated to produce both stimulators and inhibitors of synthetic state smooth muscle in culture .
The most obvious question about such inhibitors is its source of synthesis. One possibility is suggested by a report by Haudenschild and collaborators. They found that the maximum extent of proliferation of smooth muscle cells occurred in the region of the ballooned rat aorta which was last to become recovered by the regenerating endothelial sheet. These authors suggested that the endothelium somehow inhibited smooth muscle proliferation (Haudenschild and Schwartz, 1979) . A possible biochemical basis for this observation was provided by the studies of Castellot et al. (1982) and . These workers showed that endothelial cells were capable of producing a heparinlike glycosaminoglycan able to inhibit smooth muscle growth. Medium conditioned by confluent endothelial cells inhibits the proliferation of serumstimulated subcultured smooth muscle cells, whereas conditioned medium from proliferating endothelial cells and from proliferating or confluent subcultured smooth muscle cells and fibroblasts do not inhibit smooth muscle cell growth (Castellot et al., 1981; . A feeder layer of confluent, contractile smooth muscle cells (which is above the critical cell density and does not undergo the spontaneous phenotypic change) or confluent endothelial cells also prevents sparsely seeded contractile smooth muscle cells from spontaneously modulating their phenotype. In contrast, co-culture with confluent adventitial fibroblasts or subcultured synthetic state smooth muscle cells or subconfluent proliferating endothelial cells does not prevent the spontaneous phenotypic change of contractile smooth muscle . Exogenous heparin at 10 /zg/ml inhibits growth, while most other glycosaminoglycans have no effect (Hoover et al., 1980; Castellot et al., 1981 Castellot et al., , 1982 . Anticoagulant and non-anticoagulant heparin are equally effective in inhibiting smooth muscle cell growth as they are in vivo in preventing the formation of myointimal thickening following endothelial denudation (Clowes and Karnovsky, 1977; Guyton et al., 1980) . Synthesis of this material is not limited to endo-thelial cells. Fritze et al. (1985) , continuing the work of Castellot, have shown that smooth muscle cells also make a growth inhibitory heparan sulfate. This material is most prominent in quiescent cultures. Thus the quiescent, untraumatized wall may be refractory to stimulation by PDGF (Fritze et al., 1985) . It is conceivable that heparan sulfate released from quiescent endothelial cells could inhibit smooth muscle cell proliferation as the region becomes covered with endothelium. Maintenance of the normal wall in a quiescent state could reflect heparan sulfate synthesis by both endothelial cells and smooth muscle cells. The observation that vessel wall cells can produce a connective tissue molecule able to maintain smooth muscle in the contractile phenotype and inhibit proliferation suggests an intriguing mechanism for maintaining cells in a quiescent state. One could imagine that balloon denudation results in a release of enzymes that digest the extracellular matrix, removing its inhibitory effect and thereby allowing the cells to replicate. Platelets contain a heparan sulfate degrading endoglycosidase that could act in this way (Wasteson et al., 1976 (Wasteson et al., , 1977 . Incubation of endothelial cells with a crude platelet enzyme preparation or with a partially purified preparation of heparan sulfate degrading endoglycosidase from the same source causes a marked release of cell surface heparan sulfate which appears in the incubation medium as oligosaccharides. The platelet endoglycosidase (heparitinase) scissions heparin-like species at the relatively rare glucuronsyl-glucosamine bonds outside the highly sulfated regions (Oosta et al., 1982) . Castellot et al. (1982) proposed that, following endothelial denudation or injury, platelets are deposited on the subendothelium releasing heparitinase, platelet factor 4, and PDGF. The heparitinase cleaves heparin-like substances on the endothelium and smooth muscle into fragments which diffuse away, with additional inactivation of the substance by platelet factor 4 (Handin and Cohen, 1976) . With the heparin-like substance removed, smooth muscle cells may undergo phenotypic changes from the contractile to synthetic state and also be released from growth inhibition. PDGF and other mitogens can then act on the cells to stimulate their proliferation. Thus, it is possible that balloon injury allows growth by initiating breakdown of heparan sulfate and stimulates growth by platelet-derived mitogens.
This hypothesis, however, does not explain the continuation of proliferation lasting weeks after the balloon, while platelet release lasts only hours to days. Several possibilities exist. PDGF itself is very sticky and could remain active in the wall for many days. In culture experiments, Smith et al. (1982) found that residual PDGF on the culture dish could maintain smooth muscle cell growth for days, even in the presence of medium containing no PDGF. This may well explain the claims of Savion et al. (1982) 
that cells can grow on 'extracellular matrices'
Circulation Research/Vol. 58, No. 4, April 1986 prepared by detergent solubilization of cell cultures grown in the presence of growth factors. We might also consider the possibility that the initial traumatic stimulus could result in release of mitogens from damaged vessel wall cells. The failure of small areas of endothelial denudation to elicit smooth muscle replication may even be due to a lack of injury to smooth muscle cells, rather than to the lack of extensive endothelial cell loss. This idea is supported by a number of circumstantial observations. In our hands, the balloon method causes a variable amount of smooth muscle death within the media. The selective denudation used by Michael Reidy causes no apparent cell death. Recently, Gajdusek and Schwartz (1984) have reported that dead smooth muscle cells release a cytoplasmic mitogen distinct from PDGF. Interestingly, Imai et al. (1976) have implicated cell death as a critical factor in stimulation of smooth muscle proliferation in fat-fed swine. They find a high correlation of cytotoxicity and atherogenic potential attributed to the extent of oxidation in cholesterol preparations used to feed the animals.
In addition to release by blood cells or damaged vessel wall cells, growth factors may be synthesized by the vessel wall cells themselves. Endothelial cells, grown in serum from medium or in platelet-free plasma-derived serum, secrete polypeptide mitogens that can stimulate smooth muscle replication. This material was not generally seen in the inhibitor studies described above, because these experiments were done in medium containing whole blood serum that already had high levels of PDGF. Moreover, conditioned medium from endothelial cells loses its mitogenic activity when filtered, as is usually done to reuse the medium on other cells . When medium with serum, lacking platelet release, or serum-free medium, is conditioned, high levels of mitogenic activity are detected. Part of this activity is due to a material which competes with the PDGF receptor and is neutralized by the PDGF antibody. The identity of the non-PDGF mitogen remains unknown (DiCorleto, 1984; Gajdusek, 1984) . The PDGF gene is expressed at high levels by cultured endothelial cells, whereas only low levels of expression of the PDGF gene are seen in endothelium in vivo (Barrett et al., 1983) . We do not know whether these levels can be altered in vivo.
Perhaps more surpirsing is recent evidence that smooth muscle cells may be able to stimulate their own growth by synthesis of both PDGF and IGF-1. Clemmons (1984) has found that PDGF is able to stimulate smooth muscle cells to produce IGF-1. This is particularly interesting because of evidence cited above that IGF-1 is a co-factor that smooth muscle cells require for completion of the cell cycle following stimulation with PDGF (O' Keefe and Pledger, 1983; Singh et al., 1983; Clemmons, 1984; Russell et al., 1984) . The role of IGF-1 in growth responses of the vessel wall is unexplored.
The discovery that cultured smooth muscle cells from fetal rats spontaneously produce PDGF-like material grew out of the observation that growth of smooth muscle cells derived from newborn rat aortas cannot be arrested by putting cells in PDGFdeficient serum (Seifert et al., 1984) . The culture medium from these fetal cells stimulates 3T3 cell and smooth muscle cell replication. The mitogen responsible for this activity is inactivated by anti-PDGF antibody, and the conditioned medium competes for the PDGF receptor. Thus, it appears likely that fetal smooth muscle cells, at least in one species, can make this important mitogen (Seifert et al., 1984) . There is also evidence that adult smooth muscle cells can be induced to produce similar material. Cultured rat arterial smooth muscle cells produce low or absent levels of PDGF-like material. When cells are derived from a ballooned vessel, these cells produced levels similar to the levels seen in cultured cells from the immature aorta (Walker et al., 1984) . It is important to point out that, since these observations can only be made on cells placed in culture, there is no direct evidence for comparable levels of production in vivo. Nonetheless, the appearance of activity in cells derived from the balloon-injured vessel implies that some dramatic change has occurred in the capabilities of the smooth muscle cells making up the injured vessel wall. It is intriguing to consider the possibility that this change could be responsible for both the commitment to replication and the maintenance of replication during the days and weeks after injury. As with the endothelial cell-derived mitogen, interpretation of these observations depends on whether the results reflect some property in vivo. The apparent developmental control of expression, however, must occur in vivo, and remains an important area for exploration.
In summary, the emerging picture of growth control in arterial smooth muscle is a complex balance of forces. In addition to exogenous stimuli to cell growth, the vessel wall is capable of synthesis of endogenous gTowth inhibitors and growth stimulants. Based on studies of cultured cells, this seems to be a constitutive property of fetal smooth muscle cells, as well as an acquired property of smooth muscle cells obtained from a proliferating lesion. As we have noted, moreover, replicating smooth muscle cells in vivo and in cell culture resemble the relatively undifferentiated cells seen in the fetal aorta. By analogy to the established correlation of differentiation and replication in the skeletal muscle cell, it is reasonable to speculate on possible ways control of differentiational status might determine whether smooth muscle cells proliferate in response to an exogenous stimulus and continue to replicate once that stimulus is removed.
How Does Replication Affect Clinical Outcome?
While the "common sense' view of atherosclerosis seems to be that vascular occlusion is due to accu-mulation of lipid and thrombosis, these changes appear to be complications of a characteristic lesion having a lipidaceous core covered by a proliferative and synthetic mass of smooth muscle cells. Although it is unlikely that the fat mass or the smooth muscle mass becomes occlusive by itself, it would be highly unusual to see a vessel occluded by a pure accumulation of lipid in the vessel wall. Indeed, there is general consensus that the largely fatty lesions seen in children either regress or are replaced by the clinically important fibromuscular masses seen in adults (McGill, 1984) . Thus, intramural fat deposition alone does not lead to vascular occlusion, and smooth muscle proliferation is at least a necessary concomitant event (Wissler, 1974; Ross, 1981) .
There are several other reasons for being particularly concerned about smooth muscle proliferation in atherosclerosis. A high proportion of cardiac and central nervous system death is believed to result from spasm of damaged vessels. The association of this change with atherosclerotic lesions has been shown angiographically by repeated intracoronary or intravenous injection of histamine into miniature swine with diet-induced atherosclerosis (Shimokawa et al., 1983) . This phenomenon is also seen following mechanical injury to arteries. A recent report from Clowes et al. has shown that vessel wall proliferating in response to trauma is in an unusual and as yet unexplained tonic spastic state (Clowes et al., 1983) . The mechanism of this effect is not known, but might be due to a lack of endothelium, with the result that the recently described endothelial-derived relaxing factor (EDRF) is not produced, and there is no compensatory relaxation after stimulation by an agonist (Furchgott, 1983) . It is important to consider the possible clinical role of such spasm in coronary artery occlusion.
Finally, the proliferating smooth muscle cell has distinctive properties that may explain some of the properties of the atherosclerotic plaque . Particularly important are suggestions that cell proliferation may enable cells to alter the structure of lipoproteins and change rates of internalization. Similarly important are reports of differences in the production of extracellular matrix (Burke and Ross, 1977; Fischer-Dzoga, 1979; Chait et al., 1980; Davies and Ross, 1980; Fogelman et al., 1980; Henriksen et al., 1981; Shechter et al., 1981; Davies and Kerr, 1982; Campbell et al., 1983 Morel et al., 1983; Oram et al., 1983; Stout and Bierman, 1983; Wight et al., 1983; Alavi and Moore, 1984; Wight, 1985) .
What Controls the Form of Smooth Muscle Replication Seen in Atherosclerosis?
Until this point, we have discussed the accumulation of smooth muscle cells in the atherosclerotic intima as a simple problem of each cell undergoing mitosis, to become two. The localization of the cells to the intima, however, requires an explanation. In human atherosclerosis, lesions of fat-fed animals, and in lesions of vessels subjected to trauma endothelial denudation, the accumulation of smooth muscle cells is confined to the intima. Indeed, the media underlying lesions in humans typically is thinned as if depleted of its normal cellular content. This intimal pattern has led to the hypothesis that migration from the intima to the media is a critical part of lesion formation (Schwartz and Ross, 1984) .
The most direct evidence for this comes from a recent cell kinetic study (Clowes and Schwartz, 1985) . In this study, rats with balloon-denuded carotid arteries were labeled by continuous infusion with tritiated thymidine. All cells entering the cell cycle over 2 weeks were detected by autoradiography. During this interval, the increase in DNA of the media could be accounted for by about three cell doublings. About 90% of the cells in the intima were labeled and, therefore, must represent cells that moved into the intima and replicated on one or both sides of the internal elastic lamina. Since the average labeled cells must have divided three times, the 10% of the cells remaining unlabeled represents about 50% of the total migration into the intima (1 cell with three divisions = 8 labeled cells; 1 cell with migration alone = 1 unlabeled cell). Thus, substantial amounts of migration occur even without replication. Controls over migration have only begun to be explored. Already a strong contender for this role is PDGF. This peptide not only is mitogenic for smooth muscle cells, but is chemotactic as well (Grotendorst, 1984) . In contrast, other mitogens are not chemotactic. Thus, PDGF by itself could account for several major features of atherosclerosis.
It is intriguing to consider the possibility that movement of cells away from the densely populated media may release these cells from normal forms of density-dependent growth control. This could account for the persistence of replication at late periods after balloon injury, as discussed above, as well as for the propensity of atherosclerotic lesions to develop in the intima.
Hypertension
Is Replication a Result or Cause of the Disease?
DNA synthesis by hypertensive smooth muscle cells in large vessels consists of DNA duplication without either karyokinesis or cytokinesis. This results in hypertrophic, polyploid cells that account for most of the increased mass of the hypertensive vessel (Owens and Schwartz, 1982; Goldberg et al., 1984) . Whereas evidence for small vessels is more limited, the available data suggest that these vessels show a true hyperplasia, that is, an increase in the number of diploid cells (Halpern et al., 1979; Mulvany, 1982 Mulvany, , 1984 . However, this distinction between hyperploid replication and true proliferation may not be critical to the most important implication of a proliferativp response to hypertension. Maintenance of high blood pressure implies either chronic Circulation Research/Vol. 58, No. 4, April 1986 stimulation by a stimulus exogenous to the vessel wall, or a chronic change in the responsiveness of the vessel wall. The latter hypothesis implies a sort of 'memory*-that is, one might imagine some sort of initial stimulus, an as yet undefined injury, that results in a chronic change we recognize as high blood pressure. This sort of "memory* might occur at many levels, ranging from resetting of renal or central physiological mechanisms, positive feedback regulation of electrolyte levels, or direct changes in the effector system-the smooth muscle cells themselves. Changes in DNA content of the vessel wall are a simple alternative. If one imagines that the microvasculature replicates in response to episodes of acute hypertension, then the wall would retain an increased DNA content as a 'memory* of the earlier event. In turn, this increased DNA could alter the ability of the vascular system to regulate synthesis and degradation of the contractile protein mass of arterial smooth muscle cells, possibly producing a fixed increase in peripheral vessel wall mass. Such a mechanism might account for the well-established increase in structural resistance of the peripheral vasculature in humans and animals with hypertension (Folkow, 1982 (Folkow, , 1984 .
What Causes the Replication?
Whereas DNA synthesis in large vessels follows a peculiar polyploid form of cell replication, replicative responses of microarterial smooth muscle may be different. Bevan (1976) , using a coarctation model, has demonstrated that DNA synthesis occurs in response to hypertension. Although the microvascular data were not quantitative, there appeared to be a rough correlation with the replication observed in large vessels, showing an increase within 3 days of onset of hypertension with a gradual decrease over the following days and weeks (Bevan, 1976) . The etiology of this microvascular response is not known, but some hints are available from simple morphological studies. Elevation of pressure in this model is rapid and severe, analogous to malignant hypertension. The presence of endothelial denudation and platelet aggregation at sites of severe vasodilation suggests that smooth muscle replication in this model is directly comparable to the balloon-denudation model of response of large vessels. Endothelial denudation is a consistent finding in small arterioles of several animal models for high blood pressure Beilin, 1972a, 1972b; Giese, 1973; Reidy and Schwartz, 1982) . Furthermore, this microvascular change is specifically associated with focal areas of extreme dilation with high levels of permeability to plasma solutes Beilin, 1972a, 1972b; Giese, 1973) and endothelial denudation with thrombosis Beilin, 1972a, 1972b; Reidy and Schwartz, 1982) . Certainly this suggests that a platelet-dependent mechanism may be operative. There is indirect evidence for this. Some years ago, Crane and Dutta (1963) published an interesting autoradi-ogTaphic study. They found a diffusion gradient of replication at sites of hypertensive injury. Replication was prominent in the endothelium and smooth muscle cells of small renal arteries. Low levels were seen in the adjacent fibroblasts, and still lower but significant levels of replication were seen in adjacent epithelium of the collecting tubules. As they propose, these data suggest a role for a diffusible factor released at the site of injury (Crane and Dutta, 1963) . It is intriguing to consider the possibility that this factor could be PDGF released at sites of focal denudation and microthrombosis.
The denudation/PDGF hypothesis, however, cannot explain what happens in large vessels since, as already mentioned, even severe hypertension does not cause denudation in these vessels. Moreover, whereas severe hypertension usually studied in animal models leads to denudation in small vessels, there is no reason to believe that these acute events occur over the time course of the chronic hypertension more typical of man. There is evidence that changes in vessel wall mass occur in coarctation hypertension, even in protected vessels. This suggests the presence of a humoral trophic factor that might also affect DNA synthesis (Plunkett and Overbeck, 1985) . It is also possible that the sympathetic nervous system plays a role in these processes. Although it has long been recognized that motor nerves can exert a trophic influence on skeletal muscle (Gutmann, 1976) , only recently has it been shown that sympathetic nerves can also exert a trophic influence on the structure and function of smooth muscle. Bevan and Tsuru (1979) found that sympathectomy inhibited the increase in DNA mass of the developing rabbit ear artery. Similarly, Rorive et al. (1980) found that the ability of antihypertensive drugs to inhibit smooth muscle DNA replication depended on the presence or absence of effects on the sympathetic nervous system.
Denervarion of the expansor secundariorum muscle of the 2-week and adult chicken, by sectioning the brachial plexus, results in an appropriate 2-fold increase in dry weight over 8 weeks which is due to hyperplasia of the smooth muscle cells . These findings are consistent with cell culture studies where the presence of sympathetic nerve fibers in association with single isolated smooth muscle cells inhibits their phenotypic modulation to a synthetic state and subsequent proliferation in response to serum factors . The addition of sympathetic chain hemogenate has a similar inhibitory effect, demonstrating that the trophic effect is elicited by a chemical substance.
In summary, the stimuli controlling smooth muscle replication in hypertension remain unknown. PDGF may play an important role in microvascular changes in malignant hypertension, but is not likely to be involved in large vessels or in any vessel affected by milder and more chronic forms of high blood pressure. Wall tension and sympathetic activity are intriguing alternatives that need more exploration.
How Does Replication Affect Clinical Outcome?
Whether increases in arterial DNA are important in maintenance of elevated peripheral resistance depends on as yet unanswered questions. We do know what happens to the increase in vascular DNA when high blood pressure is treated. Wolinsky (1972) showed that the increase in DNA mass remains even after antihypertensive therapy has affected a decrease in wall mass. Unanswered questions are: (1) How does an increase in the number of cells or the amount of DNA per cell or total DNA per vessel length affect the steady state mass of the vessel wall? (2) How does it affect the response of the vessel wall to trophic stimuli from nerves or circulating factors? (3) How does an increased amount of DNA affect the response to subsequent hypertensive episodes?
What Controls Two Forms of Replication?
As we discussed, the smooth muscle replication characteristic of atherosclerosis consists of true diploid replication. That may also be true of smooth muscle replication in small hypertensive blood vessels. Moreover, as already discussed, the mechanism of tetraploid replication may be irrelevant to our understanding of the relationship of mass changes in vessel wall protein to vessel wall changes in DNA.
This leaves open the question of why smooth muscle cells in large vessels undergo tetraploid replication. It is intriguing to consider the possibility that the presence of two distinct forms of cell proliferation in these two diseases could provide clues as to different growth controls. It is also possible that tetraploid cells have distinct physiological properties that explain some of the differences in physiology between normal and hypertensive vessel walls (Bohr, 1981) .
To consider possible mechanisms of tetraploid replication, we need to review the cell cycle as shown in Figure 3 . PDGF and other mitogens initiate the events leading to DNA synthesis at a point called Go (Stiles, 1983) . At this point, the cells are diploid, and a series of genes is needed to be activated to synthesize proteins required for progression through the *Gi" phase of the cell cycle and, alternatively, initiate DNA synthesis (Stiles et al., 1979; Stiles, 1983; Kelly et al., 1983) . Since tetraploid replication also requires DNA synthesis, a series of events of this sort must also occur in the hyperploid replication of hypertension. Polyploidy itself occurs when replicating cells arrive at mitosis (M) but fail to complete karyokinesis or cytokinesis. One hypothesis is that the "signal" initiating replication also determines whether the cell will undergo mitosis or DNA conlanl of G, cells 2C 4C 8C , that is, twice the  haploid value), polyploid endoreplication of a  diploid results in a single cell with twice the  normal diploid DNA content (4C). This tetraploid cell may itself undergo polyploid endoreplication to produce one octaploid (8C) progeny, or it may undergo normal mitosis to produce two tetraploid daughter cells. Reductive  replication, that is, a return to diploid endoreplication. If this is the case, one would have to imagine that the signal itself or some secondary signal persists until the G 2 and M phases of the cycle. A somewhat simpler hypothesis is that failure of normal mitosis is determined by the environment of the cell or the cell's differentiation status at the point in time where mitosis begins. This is particularly important when we consider that true replication as seen in atherosclerosis occurs in cells which have migrated into the intima, while endoreplication in hypertension occurs deep within the densely populated media. Brodsky and Uryvaeva have considered the related question of polyploid replication in myocardial cells. They suggest that the presence of an extensive cytoskeletal apparatus in a contractile cell may prevent the formation of the normal contractile ring required to divide the cell and its nucleus (Schroeder, 1972; Brodsky and Uryvaeva, 1977) . This is analogous to the suggestion offered abovethat smooth muscle cells have synthetic and contractile states. Perhaps polyploid replication occurring in a contractile cell permits the cell to maintain its contractile mechanism while synthesizing more DNA in response to the increased mechanical requirements of elevated pressure or wall lesion. This hypothesis would suggest that the critical question in polyploid replication is the identity of factors that maintain the cells of the hypertensive wall in a differentiated state. We are still left without a clear idea of the identity of the stimulus that initiates DNA replication itself.
FIGURE 3. Polyploid cell cycles. Polyploidy results when cells fail to divide the nucleus (or the cytoplasm) during mitosis. Instead of a normal mitosis resulting in two daughter cells with a diploid DNA content QC
Possible Commitment Events for Replication
Smooth muscle replication in atherosclerosis and in the hypertensive microvasculature may represent a common set of mechanisms. At present, the balloon catheter denudation model is the only extensively studied in vivo model for this set of responses. This model has usually been interpreted as evidence that platelet-released factors stimulate smooth muscle growth. There are, however, a number of reasons for considering the possibility that other mechanisms, particularly smooth muscle differentiation, may play a role here as well. Three relevant pieces of information have been discussed above. Smooth muscle cells in vivo are not stimulated to replicate by denudation unless the injury is severe (Reidy and Silver, 1985) . Similarly, smooth muscle cells isolated by enzyme dispersion are initially resistant to stimulation by PDGF and remain so as long as the contractile phenotype is maintained-for example, by keeping the cells in heparin . Finally, as already mentioned, smooth muscle replication in the balloon-denudation model continues for weeks after cessation of stimulation. Within 1 day, the thrombotic events are over, but entry of cells into the growth fraction has been completed. Only these initially recruited cells continue to replicate over the period of lesion growth. This implies that some sustained change, a 'commitment,* in the smooth muscle cells in the intima or in their environment permits these cells to continue growing long after the initial thrombotic response has ended. This concept of commitment brings us back to our earlier discussion of phenotypic modulation. A spectrum of smooth muscle phenorypes can be defined morphologically, functionally, and biochemically. The normal arterial media is largely comprised of "contractile* cells, that is, cells filled with contractile filaments and characterized by expression of the cytoskeletal proteins unique to the smooth muscle cells. In contrast, most of these features are absent in proliferating cells seen in culture and in many of the smooth muscle cells of human diffuse intimal thickenings adjacent to atherosclerotic plaques (Mosse et al., 1985) . Instead, these cells have a prominent rough endoplasmic reticulum implying a synthetic phenotype. This suggests the possibility that the commitment to replicate requires a switch from the contractile phenotype to a less differentiated, synthetic phenotype. An alternative possibility is that distinctive smooth muscle cell subtypes exist even in the uninjured arterial media. This hypothesis would suggest that commitment to proliferation depends on recruitment or activation of this subset of the population. Again, we can return to the analogy of skeletal muscle differentiation. A small population of residual immature "blast" cells is known to exist in skeletal muscle and to play a role in regeneration of this muscle (Allbrook, 1981; Gibson and Schultz, 1983; Matsuda et al., 1983; Schrag and Cameron, 1983; Allen et al., 1984) . Interestingly, as noted above, vessels subjected to atherosclerosis contain a subset of smooth muscle cells lacking desmin, one of the proteins characteristic of smooth muscle differentiation. The role of these cells in prolif era rive responses is not known. If, as a response to the balloon, a few widely scattered immature or synthetic state smooth muscle cells were stimulated to migrate into the intima, the cells could be released from controls of proliferation imposed by neighboring contractile cells. If only some of these cells were from the "blast" population, we could explain the cell kinetic data, showing that only about 50% of the cells migrating into the intima enter a proliferative state (Clowes and Schwartz, 1985) . If these cells also retained the ability of fetal smooth muscle cells to produce mitogen (Seifert et al., 1984; Walker et al., 1984) , we would also be able to explain the sustained proliferation that continues after the initial stimulation of platelet release during trauma. What is more important, selection among a smooth muscle population containing such a proliferogenic subpop-ulation could account for both the monoclonal phenotype of chronic human atherosclerotic lesions (Gown and Benditt, 1982) and the suggestion from others that monoclonality arises gradually as the human lesion evolves (Pearson et al., 1978 (Pearson et al., , 1979 (Pearson et al., , 1981 (Pearson et al., , 1983 Imai and Lee, 1983; Janakidevi et al., 1984a Janakidevi et al., , 1984b Lee et al., 1985) .
It is important to point out that neither of these hypotheses is exclusive of the other (Fig. 4) , nor do we know whether "fetal" or "blast" cells are present in the adult wall. Even if such cells exist, they would be expected to be capable of differentiation into mature "contractile" state cells. Conversely, it is clear that mature 'contractile' cells can be induced to enter a "synthetic" state and to proliferate. The central issues then may be how distinctive are the various states available to the smooth muscle cell, how reversible or irreversible are transitions from one state to another, and what controls these transitions?
Conclusions
We have tried to summarize the current state of our knowledge about smooth muscle proliferation in the two major vascular diseases. Smooth muscle replication is a central feature of both diseases and could be a central etiological factor in both diseases as well.
Three different examples of smooth muscle replication are discussed: normal development of the vessel wall, response to atherosclerosis, and response to hypertension.
Underlying our entire discussion is a question that affects all of developmental biology-that is, the need to understand the common principles controlling all forms of growth. Is the normal, nonneoplas-tic state of smooth muscle cells controlled by the same mechanism in all three examples?
